Update Shows Relatlimab + Nivolumab Slows Advanced Melanoma
Progression-free survival prolonged with relatlimab + nivolumab versus nivolumab alone for previously untreated advanced melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.